Spinal Cord Injury Treatment by Applying a Composite Scaffold Transplanted with Mesenchymal Stem Cells and Chitosan-Coated Nanostructured Lipid Carriers of Curcumin.
Karami A., Molavi AM., Babaloo H., Farhadian N.
Animal Study on Spinal Cord Injury, Chronic Inflammation, published in ACS Appl Bio Mater (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- ACS Appl Bio Mater (2025)
- Country
- United States
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 40765201
- DOI
- 10.1021/acsabm.5c00636
Abstract (original English)
Background: Spinal cord injury (SCI) is one of the long-term neurological deficits with primary and secondary damages. Various treatment strategies have not been successful in SCI treatment. The aim of this study was to design a platform containing a scaffold, an anti-inflammatory nanostructured drug, and stem cells for SCI treatment. Methods: For this aim, a fibrous composite scaffold of polyurethane/alginate was prepared using the electrospinning method. The hot homogenization method was utilized to encapsulate curcumin as an anti-inflammatory drug in the nanostructured lipid carrier (NLC). NLCs were coated with chitosan polymer (CS) in a core-shell structure for better attachment to the scaffold's surface. The scaffold was covered with CS-coated NLCs and adipose-derived mesenchymal stem cells (ADMSC). The final platform was placed in the female Wistar rat model with spinal cord injury, and the therapeutic and anti-inflammatory effects at the lesion site, as well as behavioral analysis of rats, were investigated. Results: Results confirmed successful formation of the platform with proper attachment of the cells to the scaffold surface and more cell proliferation. Spreading the cells on the scaffold confirmed this scaffold as a good extracellular matrix. The efficacy of this platform in an in vivo environment showed the successful improvement of SCI in rats by increasing the m
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewPubMed
Host immune determinants of stromal vascular fraction graft survival: Toward a concept of SVF therapy resistance - A systematic narrative review.
Systematic Review on Spinal Cord Injury, Chronic Inflammation, Immune Modulation, published in Cell Transplant (2026) — summary generated from the PubMed abstract.
- 2026
Cell Transplant - Level AMeta-analysisPubMed
Stem cell-derived exosome treatment for acute spinal cord injury: a systematic review and meta-analysis based on preclinical evidence.
Meta-analysis on Spinal Cord Injury, published in Front Neurol (2025) — summary generated from the PubMed abstract.
- 2025
Front Neurol - Level ASystematic ReviewPubMed
Brain-derived neurotrophic factor (BDNF) as biomarker in stem cell-based therapies of preclinical spinal cord injury models: A systematic review.
Systematic Review on Spinal Cord Injury, published in Tissue Cell (2025) — summary generated from the PubMed abstract.
- 2025
Tissue Cell3 citations - Level ASystematic ReviewEurope PMC
Revolutionizing neural regeneration with smart responsive materials: Current insights and future prospects
Systematic Review on Spinal Cord Injury, published in Bioact Mater (2025) — summary generated from the PubMed abstract.
- 2025
Bioact Mater5 citations - Level ASystematic ReviewEurope PMC
Conductive Nanocomposite Hydrogels for Neural Tissue Engineering: A Systematic Scoping Review of Recent Trends
Systematic Review with a reported sample of 42 on Diabetic Foot, Stroke Research, Spinal Cord Injury, Neuroinflammation, published in Adv Sci (Weinh) (2025) — summary generated from the PubMed abstract.
- 2025
- n = 42
Adv Sci (Weinh)18 citations - Level ASystematic ReviewEurope PMC
Emerging regenerative strategies for spinal cord injury: exosome-derived mechanisms and therapeutic insights
Systematic Review on Spinal Cord Injury, Neuroinflammation, published in Front Neurosci (2025) — summary generated from the PubMed abstract.
- 2025
Front Neurosci